India Botulinum Toxin Market Size & Outlook, 2023-2030
India botulinum toxin market, 2018-2030 (US$M)
Related Markets
India botulinum toxin market highlights
- The India botulinum toxin market generated a revenue of USD 252.5 million in 2023 and is expected to reach USD 525.8 million by 2030.
- The India market is expected to grow at a CAGR of 11% from 2024 to 2030.
- In terms of segment, type a was the largest revenue generating product in 2023.
- Type A is the most lucrative product segment registering the fastest growth during the forecast period.
Botulinum toxin market data book summary
| Market revenue in 2023 | USD 252.5 million |
| Market revenue in 2030 | USD 525.8 million |
| Growth rate | 11% (CAGR from 2023 to 2030) |
| Largest segment | Type a |
| Fastest growing segment | Type A |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Type A, Type B |
| Key market players worldwide | Ipsen SA, Merz Pharma, US WorldMeds, Galderma Group AG Registered Shares, Evolus Inc, Allergan, Metabiologics, Lanzhou Institute Of Biological Products |
Other key industry trends
- In terms of revenue, India accounted for 2.3% of the global botulinum toxin market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Asia Pacific, China botulinum toxin market is projected to lead the regional market in terms of revenue in 2030.
- China is the fastest growing regional market in Asia Pacific and is projected to reach USD 1,443.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Botulinum Toxin Market Scope
Botulinum Toxin Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
India botulinum toxin market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to botulinum toxin market will help companies and investors design strategic landscapes.
Type a was the largest segment with a revenue share of 98.77% in 2023. Horizon Databook has segmented the India botulinum toxin market based on type a, type b covering the revenue growth of each sub-segment from 2018 to 2030.
India is currently the third largest market in the APAC region, after China and Japan. Key market drivers include increasing affordability of esthetic procedures along with growing disposable income & awareness about these procedures.
According to the International Society of Aesthetic Plastic Surgery, nearly 166,344 injectable procedures were performed in the country, with 99,384 botulinum toxin procedures in 2021. The high number of cosmetic procedures in India can be attributed to the rising disposable income and growing awareness about various cosmetic procedures.
Moreover, lower treatment costs in the country are expected to contribute to the growing medical tourism. Exposure to various social media apps and the increasing influence of global beauty standards have led to a rise in the demand for cosmetic procedures among teenagers, fueling market growth.
Reasons to subscribe to India botulinum toxin market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of India botulinum toxin market databook
-
Our clientele includes a mix of botulinum toxin market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the India botulinum toxin market , including forecasts for subscribers. This country databook contains high-level insights into India botulinum toxin market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
India botulinum toxin market size, by product, 2018-2030 (US$M)
India Botulinum Toxin Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
